Board & Management


Ebba Fåhraeus, b. 1963. Chairman of the Board, elected 2018

MBA from the Stockholm School of Economics, Sweden. Ebba Fåhraeus is CEO of SmiLe Incubator in Lund, is a member of the boards of the Faculty of Medicine at Lund University, Carasent ASA, Skandia's General Assembly and Coala Life. She has deep and wide experience in business development, growth strategies and marketing in both listed and non-listed life sciences companies.

Holdings in AcuCort: 79,960 shares, 88,888 warrants.

Anna Eriksrud, b. 1958. Director of the Board, elected 2017

International MBA from Uppsala University, Sweden. Anna Eriksrud has a background as a health care entrepreneur with over 25 years of experience in the medical and pharmaceutical sector, primarily from Q-Med and Pharmacia. She has run her own business through Apoteksamariten and has leadership experience from international cross-functional teams, establishing new market categories and launching global brands both in Europe and the US. Anna Eriksrud is CEO of NeoDynamics AB.

Holdings in AcuCort: 16,177 shares, 44,444 warrants.

Alexandra Johnsson, b. 1971. Director of the Board, elected 2018

Master of Science in International Economics from Umeå University, Sweden. Alexandra Johnsson has over 20 years' experience in marketing and sales in leading positions in both global and small-scale development companies. Most recent she held a position as the Nordic Marketing Manager for Zonnic's non-prescription nicotine products.

Holdings in AcuCort: 10,500 shares, 44,444 warrants.

Göran Tornling, b 1947. Director of the Board, elected 2021

M.D., Ph.D., and Associate Professor in pulmonary medicine at Karolinska Institutet, Stockholm. Göran Tornling has more than 20 years’ experience from all phases of clinical development in the pharmaceutical industry and he has held leading positions at AstraZeneca, Orexo and a number of smaller life science companies. Today he serves as Chief Medical Officer at Gesynta Pharma AB and AnaMar AB as well as Senior Advisor at Vicore Pharma AB.

Holdings in AcuCort: 0 shares, 44,444 warrants.

Monica Wallter, b 1956. Director of the Board, elected 2021

International diploma in marketing & economics from Lund University. Monica Wallter has a long experience and a solid background that is characterized by leading positions in well-known pharmaceutical and life science companies. Since 2000, Monica has, among other things, acted as CEO of the listed companies Probi AB and Ellen AB. In 2015, she took over as CEO of listed LIDDS AB and in 2021, she moved to the role of Senior Advisor in the same company. Her previous career includes experience from 15 years of international management positions and global leading positions in the Pharmacia Group. Chairman of Board in First Corner AB and Top Rider AB.

Holdings in AcuCort: 0 shares, 44,444 warrants.


Jonas Jönmark, b. 1971. CEO since August 2020

Jonas Jönmark has an MBA degree from Lund University, Sweden. He has more than 20 years’ experience from leading positions as well as the CEO role in the pharmaceutical industry and the life science sector. His career has included big international pharma companies such as Pfizer, Astellas Pharma and Astra Zeneca, but also smaller start-up companies such as LifeScience Support  and Alteco Medical. Jonas Jönmark has a broad experience from international business development, global product launches and creating strong sales growth.

Holdings in AcuCort: 10,563 shares, 133,336 warrants.